AESL reports strong Q1 FY26 results, with revenue up 92% and profit after tax up 173%. Expanding operations globally.

Market integrity is non-negotiable. A lapse here can put both capital and personal data at risk. 2. Brokerage Struc ...

Explore Inovio Pharmaceuticals' Q2 2025 earnings call highlights, including progress on INO-3107, regulatory milestones, financial updates, and ...